Q4 Earnings Forecast for Edap Tms Issued By HC Wainwright

Edap Tms S.A. (NASDAQ:EDAP - Free Report) - Stock analysts at HC Wainwright issued their Q4 2026 earnings per share estimates for shares of Edap Tms in a research report issued on Friday, May 16th. HC Wainwright analyst S. Ramakanth forecasts that the medical equipment provider will post earnings per share of ($0.08) for the quarter. HC Wainwright currently has a "Buy" rating and a $19.00 price objective on the stock. The consensus estimate for Edap Tms' current full-year earnings is ($0.60) per share. HC Wainwright also issued estimates for Edap Tms' FY2029 earnings at $0.31 EPS.

Several other equities analysts also recently weighed in on EDAP. Wall Street Zen initiated coverage on Edap Tms in a research report on Thursday, May 15th. They set a "hold" rating on the stock. Piper Sandler downgraded Edap Tms from an "overweight" rating to a "neutral" rating in a research note on Thursday, May 15th. Finally, Jefferies Financial Group reissued a "hold" rating and issued a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a research note on Friday, April 4th.

Edap Tms Price Performance

EDAP stock traded down $0.03 on Monday, reaching $1.77. 19,549 shares of the company's stock were exchanged, compared to its average volume of 98,663. The stock has a fifty day moving average of $1.87 and a 200-day moving average of $2.21. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The firm has a market cap of $66.18 million, a PE ratio of -2.72 and a beta of 0.13. Edap Tms has a twelve month low of $1.26 and a twelve month high of $6.14.

Edap Tms (NASDAQ:EDAP - Get Free Report) last posted its earnings results on Thursday, May 15th. The medical equipment provider reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The business had revenue of $16.37 million for the quarter, compared to analysts' expectations of $16.56 million.

Hedge Funds Weigh In On Edap Tms

A number of large investors have recently modified their holdings of EDAP. Illumine Investment Management LLC bought a new stake in Edap Tms in the fourth quarter valued at approximately $50,000. Jane Street Group LLC lifted its stake in shares of Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock worth $69,000 after buying an additional 73,361 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after buying an additional 25,650 shares during the last quarter. Millennium Management LLC raised its stake in Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after purchasing an additional 33,558 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in Edap Tms by 33.9% in the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock valued at $147,000 after buying an additional 19,000 shares during the period. 62.74% of the stock is currently owned by institutional investors and hedge funds.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.